Horizon Therapeutics Public Ltd Co

Schonfeld Strategic Advisors LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

538,836

Value ($000)

62,338

Weight

0.6%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	62,338	0.6%	538,836	9/30/2023
2023 Q2	8/14/2023	17,215	0.1%	167,384	6/30/2023
2023 Q1	5/15/2023	2,679	0.0%	24,542	3/31/2023
2022 Q4	2/14/2023	17,358	0.1%	152,532	12/31/2022
2022 Q3	11/14/2022	9,923	0.1%	160,343	9/30/2022
2022 Q2	8/15/2022	9,245	0.1%	115,921	6/30/2022
2022 Q1	5/16/2022	6,106	0.1%	58,040	3/31/2022
2021 Q4	2/14/2022	2,284	0.0%	21,200	12/31/2021
2021 Q3	11/16/2021	7,570	0.1%	69,109	9/30/2021
2021 Q2	11/16/2021	4,936	0.1%	52,717	6/30/2021
2021 Q1	5/17/2021	3,826	0.1%	41,563	3/31/2021
2020 Q4	2/16/2021	1,704	0.0%	23,300	12/31/2020
2020 Q3	11/19/2020	10,291	0.2%	132,475	9/30/2020
2020 Q2	8/14/2020	2,491	0.1%	44,812	6/30/2020
2020 Q1	5/15/2020	799	0.1%	26,967	3/31/2020
2019 Q4	2/14/2020	1,645	0.0%	45,409	12/31/2019